Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Wound Infection

ClinicalTrials.gov lists 926 trials for Wound Infection or a narrower condition beneath it.

MeSH D014946 Infections C01
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 22 Phase 1/2 Phase 1/2 10 Phase 2 Phase 2 35 Phase 2/3 Phase 2/3 16 Phase 3 Phase 3 90 Phase 4 Phase 4 129 Not applicable Not applicable 464 Observational Observational 159 Phase 1 Phase 1 22 Phase 1/2 Phase 1/2 10 Phase 2 Phase 2 35 Phase 2/3 Phase 2/3 16 Phase 3 Phase 3 90 Phase 4 Phase 4 129 Not applicable Not applicable 464 Observational Observational 159

Trials per phase (log scale)

1 more section with rows

261 of the 926 trials are tagged with Wound Infection itself; the rest are tagged with a narrower condition beneath it.

Get the Wound Infection report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Wound Infection trials start? (28)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 67

1994: 2 trials (Not applicable 1, Phase 4 1) 1995: 1 trials (Phase 2/3 1) 2001: 4 trials (Not applicable 2, Phase 4 1, Phase 3 1) 2002: 2 trials (Not applicable 1, Phase 3 1) 2003: 12 trials (Observational 1, Not applicable 5, Phase 4 1, Phase 3 2, Phase 2/3 2, Phase 2 1) 2004: 11 trials (Not applicable 3, Phase 4 3, Phase 3 3, Phase 2 2) 2005: 4 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 1) 2006: 9 trials (Observational 3, Not applicable 2, Phase 4 2, Phase 3 1, Phase 1/2 1) 2007: 24 trials (Observational 3, Not applicable 11, Phase 4 3, Phase 3 5, Phase 1/2 1, Phase 1 1) 2008: 22 trials (Observational 3, Not applicable 9, Phase 4 3, Phase 3 4, Phase 2 3) 2009: 23 trials (Observational 2, Not applicable 9, Phase 4 5, Phase 3 4, Phase 2 2, Phase 1 1) 2010: 35 trials (Observational 4, Not applicable 17, Phase 4 4, Phase 3 7, Phase 2/3 1, Phase 2 2) 2011: 36 trials (Observational 8, Not applicable 15, Phase 4 5, Phase 3 6, Phase 2 1, Phase 1 1) 2012: 27 trials (Observational 3, Not applicable 16, Phase 4 1, Phase 3 4, Phase 2 2, Phase 1/2 1) 2013: 50 trials (Observational 13, Not applicable 28, Phase 4 5, Phase 3 1, Phase 2 2, Phase 1 1) 2014: 33 trials (Observational 2, Not applicable 9, Phase 4 9, Phase 3 3, Phase 2 6, Phase 1/2 2, Phase 1 2) 2015: 48 trials (Observational 6, Not applicable 25, Phase 4 7, Phase 3 5, Phase 2/3 1, Phase 2 2, Phase 1/2 1, Phase 1 1) 2016: 44 trials (Observational 9, Not applicable 24, Phase 4 6, Phase 3 2, Phase 1 3) 2017: 40 trials (Observational 9, Not applicable 23, Phase 4 3, Phase 3 2, Phase 2/3 1, Phase 2 1, Phase 1 1) 2018: 55 trials (Observational 11, Not applicable 20, Phase 4 16, Phase 3 5, Phase 2/3 1, Phase 2 2) 2019: 58 trials (Observational 15, Not applicable 23, Phase 4 6, Phase 3 8, Phase 2/3 1, Phase 2 3, Phase 1 2) 2020: 50 trials (Observational 9, Not applicable 23, Phase 4 8, Phase 3 6, Phase 2/3 1, Phase 2 1, Phase 1/2 1, Phase 1 1) 2021: 60 trials (Observational 13, Not applicable 32, Phase 4 8, Phase 3 2, Phase 2/3 2, Phase 2 1, Phase 1 2) 2022: 45 trials (Observational 10, Not applicable 22, Phase 4 5, Phase 3 4, Phase 2/3 1, Phase 2 1, Phase 1/2 1, Phase 1 1) 2023: 55 trials (Observational 8, Not applicable 29, Phase 4 6, Phase 3 6, Phase 2/3 2, Phase 2 1, Phase 1/2 2, Phase 1 1) 2024: 67 trials (Observational 8, Not applicable 43, Phase 4 9, Phase 3 4, Phase 2/3 2, Phase 2 1) 2025: 50 trials (Observational 7, Not applicable 36, Phase 4 4, Phase 3 2, Phase 1 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 56
2025 50
2024 67
2023 55
2022 45
2021 60
2020 50
2019 58
2018 55
2017 40

Showing 10 of 28 earlier years.

Start your 14-day trial Email me all 28 earlier years as a PDF

Forecast of the full-year count, planned starts included, not rows of this table: about 68 trials starting in 2026 and about 56 in 2027, the average of the 24 months through September, counted as registered and carried forward, with about 0.7 times the starts already registered for the rest of 2026 added. The rows of this table count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. In backtests on conditions of this size, forecasts made part-way through the year were typically off by about 15 percent and ran about 1 percent high against the count later registered; forecasts made before the year began were off by about 26 percent and ran about 20 percent low against the count later registered. The part-way figures are from forecasts that used a multiple fitted only on earlier years. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored.

Prediction, not a registry value: median of 36 months from start to primary completion across 81 trials still running at the 2026-10-09 snapshot; registered median of 21 months across 566 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Wound Infection trials in? (9)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 22
Phase 1/2 10
Phase 2 35
Phase 2/3 16
Phase 3 90
Phase 4 129
Not applicable 464
Observational 159
Expanded access 1

How many Wound Infection trials are recruiting? (10)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 43
Recruiting 86
Enrolling by invitation 10
Active, not recruiting 23
Completed 500

Showing 5 of 10 statuses.

Start your 14-day trial Email me all 10 statuses as a PDF

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Wound Infection trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Pfizer 6
Zurex Pharma, Inc. 6

Which drugs are being tested for Wound Infection? (2)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Cefuroxime 9
Vicryl 5

Interventions as named in the registry (13)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
CEZ, cefazolin sodium 27
Vancomycin 1.1% 26
Iodine povidone 24
Metronidazol 8
Standard dressing 8

Showing 5 of 13 interventions.

Start your 14-day trial Email me all 13 interventions as a PDF

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Wound Infection trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Study Fracture Related Complication 1,462 2
Other 1,154 2
Pulmonary 284 2
Renal 221 2
Cardiac 216 2

Showing 5 of 10 adverse events.

Start your 14-day trial Email me all 10 adverse events as a PDF

Which publications cover Wound Infection? (334)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial. Journal of vascular surgery 2025 Yes
The value of slough in wounds for the diagnosis of microbiology cultivation. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2025 Yes
A gelatin microneedles featuring antibacterial and reactive oxygen species scavenging properties for treating Vibrio vulnificus-infected wounds. International journal of biological macromolecules 2025 Yes
Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations. Journal of racial and ethnic health disparities 2024 Yes
The impact of infection on length of stay in adult burns: A scoping review. Burns : journal of the International Society for Burn Injuries 2024 Yes

Showing 5 of 334 publications.

Start your 14-day trial Email me the first 50 publications as a PDF

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence and rare-disease identity.

Browse all condition evidence pages